Teen Cannabis Use in Germany is Down (Despite Legalisation) — Why That Matters
Germany’s partial legalisation of cannabis came into effect on 1 April 2024, allowing adults limited possession, home cultivation (up to…
H2CBD: The Hydrogenated Altnoid With Real Medical Promise
The family of so called altnoids, novel or less common cannabinoids that are either naturally rare or synthetically derived, continues…
VIDEOS
Psychedelics Beyond Labels: New Report Urges Rapid Expansion of Clinical Trials for Transdiagnostic Therapy
A new bulletin published by MAPS (the Multidisciplinary Association for Psychedelic Studies) argues that psychedelic medicines may hold transdiagnostic therapeutic…
Ignored Voices: Families and Communities Demand Real Drug Policy Reform in Ireland
Ireland’s Oireachtas Joint Committee on Drugs Use has begun hearing powerful testimonies from families, frontline workers, community organisations, and advocates…
Growing Older, Growing Better: How Cannabinoids Could Help Aging Populations in the UK, Ireland & EU
A timely new review published in Journal of Cannabis Research suggests that cannabinoids, particularly cannabidiol (CBD) and Δ⁹-tetrahydrocannabinol (THC), may…
THC-O: The Acetylated “Altnoid” That Reflects Prohibition’s Unintended Consequences
Among the wave of cannabinoids emerging in unregulated grey markets, THC-O-acetate (commonly called THC-O) is one of the most intriguing,…
THC-P: the potent “altnoid” that shows why regulation is safer than prohibition
A new family of cannabinoids, often called altnoids, has moved from obscure chemistry papers into online shops, vape carts, and…
